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The catalytic efficiency of human rhinovirus-14 (HRV14) 3C protease as a function of solvents and other regulators has
been investigated using synthetic peptides as substrates. The proteolytic activity of HRV14 3C was found to be strongly
stimulated by a series of anions in vitro and the activation was accompanied by changed Km, kcat, and increased kcat/Km
values. A more than 72-fold increase in the 3C catalytic efficiency toward peptide substrates was observed in the presence
of 0.8 M sodium sulfate. Several approaches, including size-exclusion chromatography and chemical cross-linking experi-
ments, suggested that no oligomerization of the 3C enzyme occurred in the presence of activating anions. However, the
anions did induce a significant conformational change of HRV14 3C protease, as revealed by circular dichroism spectrometry
and tyrosine fluorescence analyses, which might contribute to 3C enzyme activation. Finally, the results obtained from 3C
protease inhibitor studies suggested that the S1 specificity pocket of HRV14 3C was mainly affected by the activating anions.
An induced-fit catalysis mechanism for viral proteases is discussed. © 2001 Academic Press
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As members of picornavirus family, human rhinovi-
ruses (HRVs), the major causative agents of common
cold, contain a single strand, positive-sense RNA ge-
nome which encodes a single viral polyprotein (Couch,
1990). This polyprotein precursor is further processed by
two viral proteases designated 2A and 3C protease. It is
believed that the 2A protease makes the first cleavage at
its own N-terminus to separate the structural capsid
proteins from the nonstructural ones, while the 3C pro-
tease processes most of the remaining sites (for review,
see Palmenberg, 1990; Porter, 1993). The catalytic activ-
ities of both 2A and 3C proteases have been found to be
essential for generation of mature viral proteins and
functional viral enzymes and thus for viral replication
(Palmenberg, 1990; Porter, 1993). The two viral proteases
are also responsible for the cleavage of several impor-
tant cellular proteins through which they participate in
the regulation of host cell metabolic process (Palmen-
berg, 1990; Porter, 1993; Wang, 2000 and the references
therein).
Sequence comparison, structural and mutational anal-
ysis, and studies with classic protease inhibitors have all
shown that HRV 2A and 3C proteases contain an active
site cysteine residue as the nucleophile (Wang, 2000 for
review). However, their overall structures are more like
serine proteases rather than the typical cysteine pro-
teases (Bazan and Fletterick, 1988; Matthews et al.,
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801994). For HRV 3C protease, the catalytic triad is com-
posed of His–Glu–Cys and is positioned as seen in
serine proteases (Matthews et al., 1994). In infected
cells, HRV14 3C is able to process the polyprotein pre-
cursor at the scissile bonds formed between Gln–Gly,
Gln–Ala, and Glu–Gly (Orr et al., 1989). However, in vitro
studies have shown that this enzyme fails to cleave the
Gln–Ala and Glu–Gly bonds present in the peptides de-
rived from the authentic polyprotein cleavage sites (Orr
et al., 1989), suggesting that additional determinants
and/or other factors may affect the 3C catalytic specific-
ity.
More detailed biochemical characterization such as
substrate requirement and catalysis mechanism for HRV
2A and 3C proteases has been conducted using highly
purified recombinant enzymes. Results reported from
different groups have shown that recombinant 2A and 3C
proteases could recognize and hydrolyze small synthetic
peptides derived from their original processing se-
quences on the viral polyprotein (Cordingley et al., 1989;
Orr et al., 1989; Sommergruber et al., 1992; Wang et al.,
997a). For example, HRV14 3C protease might require at
east six amino acids (P4/P92), with four residues up-
tream and two downstream of the scissile bond, to have
measurable cleavage activity (Cordingley et al., 1990).
ore recent data have revealed that all the required
esidues for recognition and cleavage might be located
pstream of the cleavage site since this enzyme could
leave a peptide containing a chromophore p-nitroani-
ide at P19 position (Wang et al., 1997a). It has also been
oted that the P4 position of the cleavage site should be
small non-polar amino acid that could fit into the
orresponding hydrophobic substrate-binding site of the
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81RHINOVIRUS 3C PROTEASE3C enzyme (Cordingley et al., 1989; Matthews et al.,
1994).
It has been found that the purified recombinant HRV
3C protease could cleave small peptide substrates with
Km values in the millimolar range (Cordingley et al., 1989;
Orr et al., 1989; Wang et al., 1997a). Its catalytic efficiency
easured as kcat/Km values toward these peptide sub-
trates was much lower than typical serine and cysteine
roteases (Higgins et al., 1983; Valenzuela and Bender,
973). Even compared to the purified HRV 2A protease,
he 3C protease displayed much lower cleavage activity
owards synthetic peptide substrates (Cordingley et al.,
989; Orr et al., 1989; Wang et al., 1997b). The observed
ow in vitro cleavage activity associated with HRV 3C
rotease has prompted us to study the catalytic effi-
iency as a function of various regulators. Reported here
s the discovery of a significant activation of HRV 3C
rotease by Hofmeister series anions and this activation
as been found to be accompanied with HRV 3C protein
onformational change.
RESULTS
ctivation of HRV 3C protease by anions
Purified recombinant HRV14 3C protease was able to
leave a series of synthetic chromogenic peptides con-
aining the chromophore p-nitroaniline at P19 position
Wang et al., 1997b). The apparent second order rate
onstant kcat/Km was determined as 840 M21 s21 for the
cleavage of peptide EALFQ-pNA catalyzed by the puri-
fied HRV14 3C protease (Wang et al., 1997b). Considering
the relative low catalytic efficiency of the enzyme to-
wards peptide substrates as compared to other viral
proteases and classic cellular proteases, we decided to
TABLE 1
Effects of Hofmeister Anions on HRV-14 3C Protease Activity
Anion (Na1 salt)
Relative HRV14 3C protease activity (%)
0.2 M 0.4 M 0.8 M
Control 100 100 100
F2 250 470 NDa
Cl2 110 130 150
Br2 90 85 81
l2 81 63 54
CH3CO2
2 150 181 338
SO3
22 122 220 365
SO4
22 252 680 1570
Note. Assays were performed in the absence and presence of
various anions under the typical 3C protease conditions using peptide
EALFQ-pNA as substrate (0.25 mM); 0.1 mM 3C protease was used in
these reactions. Data were taken from the reactions with substrate loss
,15%.
a ND, not done due to low solubility.examine the 3C protease activity as function of variousreagents. The 3C activity towards the pNA peptide was
first examined in the presence of NaCl at different con-
centrations. The enzyme were active in the absence of
salt; however, its activity was found to increase in re-
sponse to the salt concentrations (Table 1), and about
twofold stimulation was observed at 2.5–3 M NaCl, the
highest concentrations tested (not shown). Similar effect
was also observed with KCl and divalent cation salt such
as MgCl2, indicating this stimulating effect on the 3C
protease activity was caused by anion but not cations
(data not shown).
Encouraged by the initial results, we examined the
effect of various salts on the 3C enzymatic activity. As
seen in Table 1, the 3C protease activity could be greatly
enhanced by sulfate salts as well as sodium fluoride.
Over 22-fold increase of the 3C protease activity was
associated with the presence of 1 M sodium sulfate (Fig.
1A). This stimulation of 3C protease was dependent on
salt concentrations and did not reach the maximum at
the highest salt concentrations tested (Fig. 1A). Similar
results were obtained using potassium sulfate (data not
FIG. 1. Stimulation of HRV14 3C protease by anions. (A) Stimulation
of 3C protease activity by sodium sulfate. Reactions was performed
with 250 mM EALFQ-pNA substrate and 0.1 mM 3C protease as de-
scribed in the text in the presence of Na2SO4 at the concentrations
indicated. Absorbance at 405 nm was collected and reading from the
reaction containing no enzyme was taken as blank. (B) Effects of anion
on 3C catalytic efficiency toward different peptide substrates. Peptides
pNA2 (TLFQ-pNA) and pNA3 (RKGDISKY-pNA) were designed for
HRV14 3C and 2A protease, respectively. Their cleavage by the 3C
protease was determined under the conditions described in the text in
the absence (solid bar) and presence (hatch bar) of 0.8 M Na2SO4.
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82 WANG AND JOHNSONshown). Sulfite (SO3
22) and acetate (CH3CO2
2) salts
showed moderate stimulation with about three- to five-
fold enhancement of 3C cleavage activity seen at 0.8–1
M salt concentration (Table 1). In contrast, bromide and
iodide salts were inhibitory as shown in Table 1. The
order of anion activation of the 3C protease was ranked
as SO4
2 . F2 . CH3CO2
2, SO3
22 . Cl2 . Br2, I2, corre-
lating with the effectiveness of the Hofmerister series for
anions (Collins and Washabaugh, 1985).
To confirm that the observed 3C enzyme activation
was not substrate specific, we examined the anion ef-
fects on HRV 3C protease activity using several other
peptide substrates. For example, a 16-mer peptide sub-
strate representing the authentic 3C cleavage site on the
HRV polyprotein, -DSLETLFQ//GPVYKDLE-, could be hy-
drolyzed by HRV14 3C protease in the absence of stim-
ulating salts (Cordingley et al., 1989). It was found that
he 3C cleavage activity toward this 16-mer native pep-
ide was enhanced about eightfold in the presence of 0.8
sodium sulfate. Another pNA peptide containing four
mino acids, TLFQ-pNA, was shown previously to be a
oor substrate for HRV14 3C protease with a kcat/Km
alue of ;40 M21 s21 (Wang et al., 1997b). In the pres-
ence of 0.8 M sulfate salt, the 3C catalytic efficiency
kcat/Km toward this substrate was identified to be
;2880 M21 s21, more than 72-fold increase over the one
determined without sulfate salts. On the other hand, two
other pNA peptides, RKGDISKY-pNA (Wang et al., 1998)
and TRPIITTA-pNA (Wang et al., 1997a), designed specif-
ically for HRV14 and HRV2 2A proteases, respectively,
could not be hydrolyzed by the 3C protease either in the
absence or presence of sodium sulfate (Fig. 1B). Based
on these data, we conclude that the enhancement of
peptide hydrolysis by anions acted through the viral
protease rather than peptide substrates.
We also examined the stability of peptide substrates in
the presence of anions. These substrates were found to
be stable at various salt concentrations tested and pep-
tide cleavage occurred only when the viral protease was
present (result not shown). In parallel, the 3C protease
stability was also examined under these conditions. A
time-dependent product accumulation was observed in
both absence and presence of salts (data not shown).
Taken together, these data indicate that the observed 3C
activity enhancement by anions was not due to substrate
identity and/or enzyme stability in the assays.
To examine if other negatively charged molecules had
similar effects on HRV 3C protease activity, various nu-
cleotides were tested in the 3C cleavage reaction. Only
slight stimulation (up to 2.5-fold) was seen with mono-
phosphate nucleotides, while most of triphosphate nu-
cleotides were inhibitory (data not shown). For example,
ATP inhibited the 3C cleavage activity with an IC50 of 16
mM. As the enzyme demonstrated high tolerance to
salts, we also determined the effect of various organicsolvents and co-solvents on the 3C protease activity.
These results are summarized in Table 2.
Effects of activating anions on HRV 3C protease
kinetic parameters and inhibition profiles
To gain a better understanding on viral 3C protease
activation by anions, we performed kinetic analysis on
peptide hydrolysis reactions catalyzed by the 3C pro-
tease. In the absence of stimulating additives, the en-
zyme had a kcat/Km value of ;840 M21 s21 toward the
eptide EALFQ-pNA (Wang et al., 1997b). Further analy-
is of this reaction revealed that the Km and kcat values
ere ;1.2 mM and ;1.01 s21 toward this peptide, re-
spectively. While in the presence of 0.8 M sulfate salt, the
Km and kcat values were determined to be 0.26 mM and
3.4 s21, respectively, suggesting that these anions stim-
lated the 3C protease activity by affecting both its affin-
ty for substrate and catalytic turnover. The 3C catalytic
fficiency kcat/Km was determined to be ;13,100 M21
s21 in the presence of 0.8 M sulfate, increased about
15-fold as compared to the assay containing no salt. For
the assays containing 1 M sodium sulfate, more than
22-fold increase was observed with a kcat/Km value of
;18,480 M21 s21.
As HRV 3C protease is viewed as an excellent target
for development of antiviral agents, it would be important
to see if there is any effect of anions on interaction
between the viral protease and inhibitors. Therefore, we
examined the impact of the activating salts on 3C pro-
tease inhibition profile using both classic and specifi-
TABLE 2
Effect of Co-solvents on HRV14 3C Protease Activity
Reagent
Relative HRV14 3C protease activity (%)
1% 2% 5% 10%
Control 100 100 100 100
Acetonitrile 100 100 97 48
DMSO 100 92 83 74
Isopropanol 96 93 86 74
Methanol 100 100 98 91
Glycerol 102 104 110 114
Ethylene glycol 102 104 102 95
PEG-3400 103 100 96 90
Sorbitol 105 108 112 120
Sucrose 103 105 108 112
Note. The activity of purified 3C protease (0.1 mM) was examined in
he presence of the indicating reagent under the conditions described.
eptide EALFQ-pNA was used as the substrate at 0.25 mM in these
eactions. Effects of the testing reagents on the 3C activity was ex-
ressed relative to the control reaction with no additive. Data were
aken from the reactions with substrate loss ,20%. Shown is the
verage of two independent experiments. Sorbital, sucrose, and poly-
thylene glycol (PEG) were measured at w/v, the rest were measured
t v/v concentrations.cally designed protease inhibitors. For classic protease
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83RHINOVIRUS 3C PROTEASEinhibitors, such as iodoacetamide and N-ethylamaleim-
de that nonspecifically alkylate the 3C active site cys-
eine residue, the IC50 values were quite similar in the
absence and presence of sulfate salt (Table 3). E-64, a
classic cysteine protease inhibitor, did not inhibit 3C
protease activity at either case. For compounds that
were specifically designed for HRV14 3C protease on the
basis of the 3C substrate specificity (Table 3, Shepherd
et al., 1996; Kong et al., 1998), we found that several
tetrapeptide inhibitors showed no significant change on
their IC50 and/or IC90 values when tested in the absence
or presence of salts (Table 3). Interestingly, several
smaller inhibitors such as LY338387 and LY362270
(Shepherd et al., 1996; Kong et al., 1998), containing two
residues mimicking the P1 and P2 amino acids of the
substrate, demonstrated three- to fivefold increase in
their potency against HRV14 3C enzyme in the presence
of 0.8 M sodium sulfate (Table 3). Kinetic analysis re-
vealed that the inhibition constant Ki was also affected.
For example, the dipeptide aldehyde inhibitor LY338387
inhibited the 3C protease with Ki values of ;1.8 and ;0.5
mM in the absence and presence of 0.8 M sulfate salt,
respectively. Taken together, these data suggest that
small dipeptidic inhibitors had a stronger binding to the
enzyme in the presence of anions.
Effects of anions on the HRV 3C protease
conformation
To understand the activation mechanism of 3C pro-
TABLE 3
Effects of Anions on HRV-14 3C Protease Inhibition Profile
Inhibitor Structure
Inhibition of HRV14 3C
(IC50, mM)
Control
10.8 M
Na2SO4
E-64 NSa No inhibition No inhibition
Iodoacetamide NS 330 360
N-ethylmaleimide NS 2.22 2.47
LY366405 Boc-VLFvQ-OEt 0.13 0.15
LY387836 Boc-VLFvQ-OH 0.49 0.47
LY355455 Boc-VLFvQ-OMe 0.25 0.29
LY387842 Cbz-VLFvQ-OMe 0.17 0.18
LY362270 Cbz-FvQ-OMe 9.5 2.2
LY362829 Boc-FvQ-OMe 172.8 62.3
LY387843 Boc-FvQ-OEt 209.8 70.3
LY338387 Cbz-FM(O2)-H 2.15 0.96
Note. Assays were performed with or without anions under the
typical 3C protease conditions using peptide EALFQ-pNA as substrate
(0.25 mM); 0.1 mM 3C protease was used in these reactions. Data were
aken from the reactions with substrate loss ,15%. LY338387 and
Y387836 are peptide aldehyde inhibitors, the rest are peptide Michael
cceptors (Shepherd et al., 1996; Kong et al., 1998).
a NS, molecular structure for classic protease inhibitors is not shown.tease by anions, we examined if the activating salts wcould induce either association or dissociation of 3C
protein molecules in solution. We performed gel filtration
analysis of the HRV 3C protein in the presence and
absence of the stimulating salt as described previously
(Wang et al., 1998). Fractionation on a Superdex-75 size-
xclusion column revealed that the 3C protein eluted at
he monomer position in both absence and presence of
ctivating salt (data not shown). In addition, chemical
ross-linking experiments, using linkers reactive to both
rimary amine and thiol groups, did not capture any
ligomerized 3C protein forms and only 3C protein mono-
er was observed under various conditions examined
data not shown). We thus concluded that 3C protein did
ot exist as dimeric or any oligomeric forms in the ab-
ence and presence of testing salts.
To probe possible effects of activating anions on the HRV
C protein conformation, circular dichroism (CD) spectrom-
try analyses of 3C protein were performed. As shown in
ig. 2A, the CD spectrum of the HCV14 3C protease is quite
ifferent from that of a typical a-helical protein, consistent
ith the previous conclusion that this viral protease is rich
n b strands (Matthews et al., 1994). On the other hand, a
significant difference of the CD spectra was identified for
the 3C protein samples in the absence and presence of 0.8
M sodium sulfate (Fig. 2). For far ultraviolet range (200–240
nm) analysis, the major changes were found to be associ-
ated with the content of b sheets; it increased from 41 to
1% when sulfate salt was included. This change was
ccompanied with the decrease of the protein random coil
ontent (from 45 to 36%). In contrast, a-helix content was
ot significantly affected (Fig. 2). As the CD spectrum ob-
ained in this range reflects the contribution of various
econdary structural elements, these results indicated that
he stimulating anions caused 3C protein backbone con-
ormation change.
To examine if the overall conformation of 3C protein
as affected by activating anions, CD spectra in the near
ltraviolet range of the 3C proteins were also taken
nder the conditions described above since these spec-
ra could reflect the surface distribution of several aro-
atic amino acids present in the protein. As seen in Fig.
B, the CD spectrum of the viral 3C protease taken in the
queous solution without salt was different from that of
he protein treated with the salt, indicating a different
xposure of aromatic amino acids on the protein surface
nder the two different testing conditions.
To further confirm the conformational change of 3C
rotein induced by the stimulating salts, the fluores-
ence spectra of the 3C protein samples were generated
nder different treatments. Since HRV14 3C does not
ontain tryptophan residues, fluorescence spectra were
aken at an excitation wavelength of 280 nm, which
ould only reflect the fluorescence emission of the ty-
osine residues present in the 3C protein. As shown in
ig. 2C, tyrosine fluorescence intensity of the 3C protein
as enhanced more than 370% relative to the control
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84 WANG AND JOHNSONenzyme in the presence of 0.8 M sulfate salt. Low salt
concentrations (0.2 and 0.4 M) also caused fluorescence
intensity increase but to a lesser extent (Fig. 2C). It was
noted that the emission maximum wavelength of the 3C
protein was not affected significantly by the added salt
(not shown). In contrast, a fluorescence intensity de-
crease was seen with the 3C protein denatured by 6 M
urea (Fig. 2C). Taken together, these data implied that a
conformational change occurred on the protein architec-
ture in the presence of stimulation anions.
DISCUSSION
Previous studies have shown that the HRV 3C pro-
tease hydrolyzes synthetic peptides in vitro but with
uch lower catalysis efficiency even on its most favor-
ble substrates as compared to human immunodefi-
iency virus (HIV) protease and certain cellular pro-
eases such as chymotrypsin and thrombin (Cordingley
t al., 1989; Orr et al., 1989; Higgins et al., 1983; Meek et
al., 1989). Low catalytic efficiency toward peptide sub-
strates has also been reported for another two serine
proteases encoded by human herpes simplex virus-1
(HSV-1) and human cytomegalovirus (HCMV) (Hall and
Darke, 1995; Margosiak et al., 1996). It is interesting to
ote that these two similar viral proteases could also be
trongly activated by various anions (Hall and Darke,
995; Margosiak et al., 1996). The data documented in
his report suggest that the HRV 3C, a cysteine protease,
lso subjects to similar activation, although the 3C pro-
ein is encoded by a very different RNA virus and shares
o significant homology with the two viral proteases
entioned above.
Our results indicated that the activation of HRV14 3C
rotease by salts was a result of anions but not cations,
FIG. 2. CD spectrometric and fluorescence analyses of HRV14 3C p
spectrum. These spectra were collected using purified HRV14 3C prot
sodium sulfate as described in the text. (C) Tyrosine fluorescence spec
maximum at wavelength of 360 nm in the presence of 0, 0.4, and 0.8 M
with 6 M urea.nd the activation effectiveness of these anions wasanked in the same order as the Hofmeister series an-
ons (Collins and Washabaugh, 1985). For HSV-1 pro-
ease activation by anions, it has been proposed that
ctivating anions could cause destabilization of the free
ubstrate in solution and stabilization of the enzyme-
ubstrate complex (Hall and Darke, 1995). This might
lso apply to the HRV 3C protease; however, there were
o direct data at present time to confirm this.
On the other hand, comparative kinetic analyses of the
C cleavage reactions revealed that the activating an-
ons eventually caused an increased affinity of the en-
yme for the peptide substrates. Along with the 3C cat-
lytic efficiency increase, we observed that these anions,
t the concentrations exerting stimulation effects on the
rotease, induced 3C protein conformation changes as
hown by both CD and intrinsic 3C protein fluorescence
nalyses. However, differing from the results described
or the HCMV protease (Margosiak et al., 1996), no
imerization or oligomerization of the 3C protein was
bserved under various conditions tested. On the basis
f these data, we conclude that HRV14 3C protease was
ctivated by anions through induction of conformational
hanges at the secondary and three-dimensional but not
uaternary structure level.
The 3C protease inhibition analysis suggests that a
ignificant conformational change might happen at the
1 pocket of the viral protease. Of all the inhibitors
ested, sulfate salts could enhance the binding of dipep-
idic inhibitors to the enzyme as shown by their in-
reased potency along with lowered Ki value (Table 3).
hese inhibitors were designed to mimic the two amino
cids at P1 and P2 of the peptide substrates for HRV 3C
rotease (Shepherd et al., 1996; Kong et al., 1998). They
have been found to interact with the protease at the
(A) Far ultraviolet range CD spectrum. (B) Near ultraviolet range CD
.5 mg/ml) in the absence (solid line) and presence (dash line) of 1 M
RV14 3C protease. Columns A–C represent the fluorescence emission
sulfate, respectively. Column D is for the 3C protein sample denaturedrotein.
ease (0
tra of H
sodiumexpected S1 pocket at the active center of the 3C enzyme
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85RHINOVIRUS 3C PROTEASE(Shepherd et al., 1996; Kong et al., 1998). According to the
X-ray crystal structure of the HRV14 3C protease (Mat-
thews et al., 1994), the S1 specificity pocket is part of a
flexible loop around the active center of the 3C enzyme.
This loop is composed of amino acid residues 140–146
involved in recognition of the P1/P2 residues of the
substrates, nucleophilic attack on the scissile bond, and
stabilization of the catalytic transition state. It has been
proposed that this loop might have higher mobility than
other trypsin-like serine proteases, and its conforma-
tional stabilization was related to the 3C catalytic effi-
ciency (Matthews et al., 1994). It is interesting to note that
the random coil content of the 3C protein did decrease in
the presence of the activating anion as shown by the CD
analysis (Fig. 2). Therefore, it is conceivable that the
activating anions could induce a conformational change
of this loop; the resulting new conformation is more
stabilized and should favor small sized substrate or sub-
strate-like inhibitor bindings. As a result, the 3C protease
catalytic efficiency toward peptide substrates or the in-
hibitor potency were greatly enhanced.
It is important to note that, in infected cells, the 3C
protein is able to complex with negatively charged viral
RNA in addition to its proteolytic function. Porter and
colleagues have shown that HRV14 3C can specifically
bind to a 27-nucleotide stem–loop structure in the 59-
noncoding region of the HRV plus strand RNA (Leong et
al., 1993; Porter, 1993; Walker et al., 1995). This RNA-3C
rotein interaction has been proposed to be important
or the formation of a ribonucleoprotein complex that
atalyzes the initiation of the HRV plus-strands in trans
Andino et al., 1990). On the other hand, these findings, in
ombination with our results, may also imply that the
nzymatic activity of HRV 3C could be regulated through
his interaction. Therefore, it would be interesting to see
ow the 3C protease activity is affected by the bound
NA and if there is any conformational changes up on
he RNA binding to the enzyme.
In summary, the data presented in this report indicate
hat the catalytic efficiency of the HRV 3C cysteine pro-
ease could be greatly stimulated by water-structure
orming anions. The observed 3C activation was accom-
anied by an anion-induced conformational change of
he protein. Interestingly, a recent report described that
he NS3 serine protease encoded by human hepatitis C
irus might also have a flexible active center that is
ubjected to an induced-fit catalysis mechanism (Bar-
ato et al., 2000). Perhaps, this induced-fit mechanism is
general pattern not only for chymotrypsin-like serine
roteases encoded by various viruses but also for cer-
ain cysteine protease such as the HRV 3C protease
escribed in this report. Meanwhile, from a pharmaceu-
ical point of view, our findings can be useful for rational
esign of potent 3C protease inhibitors for treatment of
ommon cold. nMATERIALS AND METHODS
Materials
Purified recombinant HRV14 3C protease was pre-
pared using the procedures published previously (Cox et
al., 1999). The 3C enzyme preparation was further dia-
lyzed against buffer A (25 mM HEPES, pH 7.5, 1 mM
EDTA, and 25% glycerol) overnight and then stored at
280°C. Peptide substrates were prepared as described
previously (Wang et al., 1997a, 1998; Cox et al., 1999).
Classic protease inhibitors were purchased from Sigma.
Peptidic HRV 3C protease inhibitors were designed and
synthesized as described previously (Shepherd et al.,
996; Kong et al., 1998). Protein cross-linking reagents
ere purchased from Pierce.
iral protease assay
A typical 3C protease assay was performed at 30°C
or the time indicated in a 200 ml reaction mix containing
5 mM HEPES, pH 7.5, 1 mM EDTA, 250 mM peptide
substrate as specified below, and 3C protease at the
concentrations indicated. Reactions were started by the
addition of substrate. In most cases, the chromogenic
p-nitroanilide (pNA) peptide (EALFQ-pNA) was used as
the substrate under the conditions described above
(Wang et al., 1997b). Cleavage of pNA peptides between
the P1 residue and pNA at P19 by the protease releases
free pNA, whose absorbance can be measured at a
wavelength of 405 nm against a blank where either
substrate or enzyme was not included in the reaction
(Wang et al., 1997b). All reactions were directly per-
formed in microtiter plate wells and monitored using a
temperature-controlled microplate reader (Molecular De-
vices). For kinetic parameter determination, data were
collected prior to 20% substrate depletion, and the ki-
netic parameters were generated using the Michaelis–
Menten formula. The absence of products after 2-h incu-
bation of the substrate with the enzyme was defined as
no cleavage.
Circular dichroism (CD) spectrometry analysis
CD spectrometry analyses of purified 3C proteins
were performed as described previously using a JASCO
J-600 circular dichroism spectropolarimeter with cylindri-
cal cuvettes of pathlength 0.05 cm (Cox et al., 1999). Data
collection parameters were 1.0-nm bandwidth and
0.2-nm steps with a time constant of 0.25 s and a scan
speed of 10 nm/min, and averaged over three replicates.
All data were converted to mean residue ellipticity (MRE)
in units of degree 3 cm2 3 dmol21 using a mean residue
olecular weight of 109.9. The absorbance spectra of
RV14 3C protease (1 mg/ml) in the absence or pres-
nce of 0.8 M Na SO in buffer A were collected in both2 4
ear (240–350 nm) and far (190–250 nm) UV range.
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86 WANG AND JOHNSONFluorescence measurement of HRV14 3C protease
Intrinsic tyrosine fluorescence of the viral 3C protein was
measured using a Perkin Elmer LS50B fluorometer. The
fluorescence emission spectra of the purified HCV14 3C
protein (0.5 mg/ml) in the presence of 0, 0.2, 0.4, or 0.8 M
sodium sulfate was recorded from 300 to 400 nm with the
excitation wavelength of 280 nm and all slit widths at 4 nm.
To obtain the fluorescence spectrum of the denatured 3C
protein, purified 3C protein was first denatured by 6 M urea,
and the emission spectrum was then taken as described
for the native protein. All emission spectra were corrected
for background using the same enzyme buffer solutions.
Chemical cross-linking of HRV14 3C protease
Cross-linking experiments were performed using di-
succinimidyl suberate (DSS) and bismaleimidohexane
(BMH) as the linkers. These reagents are known to be
capable of generating non-cleavable cross-linked prod-
ucts with DSS reactive towards primary amines on side
chains of amino acids such as lysine, and BMH reactive
towards the thiol group of cysteine residues present in
proteins. Cross-linking reactions were performed on ice
for 2 h with 0.5 mg/ml HRV 3C protein in the buffer
containing 50 mM HEPES, pH 7.5, 1 mM EDTA, and 10%
glycerol, and 25 mM BMH or DSS in the absence or
presence of 0.8 M Na2SO4. Cross-linked products were
hen analyzed by SDS–PAGE and visualized by Coomas-
ie blue staining of the gels.
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